ARVN Arvinas, Inc.

NASDAQ
$8.16

Arvinas, Inc. (ARVN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with ARVN's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
6
23 transactions
Purchases
$495.1K
50,000 shares
Sales
$1.4M
126,256 shares
Net activity
-$926.1K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.4M 23 transactions · 126,256 shares

Largest single sale: $249.2K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 6, 2026 , by Morrison Briggs .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Saik Andrew Chief Financial Officer Sell 5,696 $8.16 $46.5K 187,432 −2.9% of holding
Cacace Angela M Chief Scientific Officer Sell 2,576 $7.59 $19.6K 180,390 −1.4% of holding
Teel Randy President and CEO Sell 2,209 $9.04 $20.0K 285,009 −0.8% of holding
Saik Andrew Chief Financial Officer Sell 11,139 $9.94 $110.7K 193,128 −5.5% of holding
Berkowitz Noah Chief Medical Officer Sell 11,108 $9.94 $110.4K 191,395 −5.5% of holding
Teel Randy President and CEO Sell 9,657 $9.94 $96.0K 287,218 −3.3% of holding
Cacace Angela M Chief Scientific Officer Sell 9,657 $9.94 $96.0K 182,966 −5% of holding
Loomis David K VP, Chief Accounting Officer Sell 1,919 $9.94 $19.1K 40,193 −4.6% of holding
Berkowitz Noah Chief Medical Officer Sell 6,435 $11.10 $71.4K 202,503 −3.1% of holding
Morrison Briggs Director Buy 20,000 $13.40 $268.1K 96,021
Houston John G 3 fills Director Sell 35,297 $13.21 $466.2K 1,152,792 −3% of holding
Teel Randy 2 fills President and CEO Sell 4,786 $12.16 $58.2K 153,444 −3% of holding
Cacace Angela M 2 fills Chief Scientific Officer Sell 3,609 $12.16 $43.9K 150,194 −2.3% of holding
Loomis David K Chief Accounting Officer Sell 1,108 $12.16 $13.5K 29,692 −3.6% of holding
Berkowitz Noah Chief Medical Officer Sell 5,685 $11.89 $67.6K 163,938 −3.4% of holding
Saik Andrew Chief Financial Officer Sell 5,134 $11.89 $61.0K 159,267 −3.1% of holding
Cacace Angela M Chief Scientific Officer Sell 4,592 $11.89 $54.6K 151,232 −2.9% of holding
Teel Randy President and CEO Sell 4,403 $11.89 $52.4K 154,482 −2.8% of holding
Loomis David K Chief Accounting Officer Sell 1,016 $11.89 $12.1K 30,800 −3.2% of holding
Loomis David K Chief Accounting Officer Sell 230 $9.89 $2.3K 31,697 −0.7% of holding
Morrison Briggs Director Buy 30,000 $7.57 $227.0K 76,021

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.